Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144]
EBioMedicine. 2017 Mar:17:238.
doi: 10.1016/j.ebiom.2017.03.010.
Epub 2017 Mar 8.
1 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: [email protected].
2 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK. Electronic address: [email protected].
3 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: [email protected].
4 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: [email protected].
5 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: [email protected].
6 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: [email protected].
7 Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Electronic address: [email protected].
8 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: [email protected].
9 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: [email protected].
10 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: [email protected].
11 Nuffield Department of Surgical Sciences, University of Oxford, Roosevelt Drive, Oxford, UK. Electronic address: [email protected].
12 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Molecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK. Electronic address: [email protected].
13 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Molecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK. Electronic address: [email protected].
14 University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Electronic address: [email protected].
15 University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Electronic address: [email protected].
16 Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK. Electronic address: [email protected].
17 Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Electronic address: [email protected].
18 Department of Pathology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Electronic address: [email protected].
19 University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Electronic address: [email protected].
20 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: [email protected].
21 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: [email protected].
22 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Prostate Cancer Research Group, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway; Department of Molecular Oncology, Institute of Cancer Research, Oslo University Hospitals, N-0424 Oslo, Norway; Prostate Cancer UK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. Electronic address: [email protected].
23 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: [email protected].
24 Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Electronic address: [email protected].